Solara Active Pharma Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for API Expertise for more than 30 Years, with 4 Manufacturing Facilities armed with Global Approvals.
One of their notable products is PRAZIQUANTEL, with a corresponding US DMF Number 26076.
Remarkably, this DMF maintains an Active status since its submission on May 21, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 04, 2016, and payment made on September 19, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II